Harmony Biosciences Holdings, Inc. (HRMY)
39.64
+0.07
(+0.18%)
USD |
NASDAQ |
Oct 02, 16:00
39.64
0.00 (0.00%)
Pre-Market: 20:00
Harmony Biosciences Holdings Gross Profit Margin (Quarterly) : 73.53% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 73.53% |
| March 31, 2026 | 76.57% |
| December 31, 2025 | 69.44% |
| September 30, 2025 | 72.60% |
| June 30, 2025 | 78.00% |
| March 31, 2025 | 79.45% |
| December 31, 2024 | 70.00% |
| September 30, 2024 | 73.80% |
| June 30, 2024 | 77.95% |
| March 31, 2024 | 78.37% |
| December 31, 2023 | 70.84% |
| September 30, 2023 | 76.13% |
| June 30, 2023 | 76.93% |
| March 31, 2023 | 77.55% |
| Date | Value |
|---|---|
| December 31, 2022 | 74.40% |
| September 30, 2022 | 75.32% |
| June 30, 2022 | 76.75% |
| March 31, 2022 | 76.79% |
| December 31, 2021 | 75.38% |
| September 30, 2021 | 76.25% |
| June 30, 2021 | 82.81% |
| March 31, 2021 | 82.56% |
| December 31, 2020 | 82.38% |
| September 30, 2020 | 82.70% |
| June 30, 2020 | 83.01% |
| March 31, 2020 | 82.49% |
| December 31, 2019 | 41.25% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Liquidia Corp. | 93.10% |
| Pfizer Inc. | 62.94% |
| Bristol Myers Squibb Co. | 67.95% |
| Repligen Corp. | 49.25% |
| Johnson & Johnson | 68.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 20.66% |
| Return on Assets | 14.54% |
| Return on Invested Capital | 16.52% |
| Profit Margin (Quarterly) | 28.87% |
| Operating Margin (Quarterly) | 34.18% |
| Return on Net Operating Assets | 82.22% |